Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 2
2008 1
2010 1
2011 2
2012 7
2013 7
2014 5
2015 4
2016 5
2017 4
2018 2
2019 2
2020 2
2021 1
2022 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers.
Guzman J, Weigelt K, Neumann A, Tripal P, Schmid B, Winter Z, Palmisano R, Culig Z, Cronauer MV, Muschler P, Wullich B, Taubert H, Wach S. Guzman J, et al. Among authors: cronauer mv. BMC Cancer. 2024 Mar 19;24(1):346. doi: 10.1186/s12885-024-12110-2. BMC Cancer. 2024. PMID: 38500100 Free PMC article.
Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.
Tolkach Y, Kremer A, Lotz G, Schmid M, Mayr T, Förster S, Garbe S, Hosni S, Cronauer MV, Kocsmár I, Kocsmár É, Riesz P, Alajati A, Ritter M, Ellinger J, Ohlmann CH, Kristiansen G. Tolkach Y, et al. Among authors: cronauer mv. Cancers (Basel). 2022 Sep 13;14(18):4441. doi: 10.3390/cancers14184441. Cancers (Basel). 2022. PMID: 36139600 Free PMC article.
Detection of AR-V7 in primary prostate cancer.
Kaczorowski A, Chen X, Kristiansen G, Bernemann C, Hohenfellner M, Cronauer MV, Duensing S. Kaczorowski A, et al. Among authors: cronauer mv. Cancer Treat Res Commun. 2021;28:100230. doi: 10.1016/j.ctarc.2020.100230. Epub 2020 Oct 24. Cancer Treat Res Commun. 2021. PMID: 33139223 Free article. No abstract available.
Antibody selection influences the detection of AR-V7 in primary prostate cancer.
Kaczorowski A, Chen X, Herpel E, Merseburger AS, Kristiansen G, Bernemann C, Hohenfellner M, Cronauer MV, Duensing S. Kaczorowski A, et al. Among authors: cronauer mv. Cancer Treat Res Commun. 2020;24:100186. doi: 10.1016/j.ctarc.2020.100186. Epub 2020 Jun 23. Cancer Treat Res Commun. 2020. PMID: 32619831 Free article.
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy.
Chen X, Bernemann C, Tolkach Y, Heller M, Nientiedt C, Falkenstein M, Herpel E, Jenzer M, Grüllich C, Jäger D, Sültmann H, Duensing A, Perner S, Cronauer MV, Stephan C, Debus J, Schrader AJ, Kristiansen G, Hohenfellner M, Duensing S. Chen X, et al. Among authors: cronauer mv. Urol Oncol. 2018 Apr;36(4):161.e19-161.e30. doi: 10.1016/j.urolonc.2017.11.001. Epub 2017 Dec 1. Urol Oncol. 2018. PMID: 29198908
Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1-3.
Cronauer MV, Merseburger AS, Hoda MR. Cronauer MV, et al. Eur Urol. 2017 Apr;71(4):e105-e106. doi: 10.1016/j.eururo.2016.09.021. Epub 2016 Sep 20. Eur Urol. 2017. PMID: 27663049 No abstract available.
36 results